Skip to content
healthcare.dev

NALOXONE HYDROCHLORIDE

NDC 45802-578, naloxone hydrochloride, spray, from Padagis Israel Pharmaceuticals Ltd.

Product NDC
45802-578
Status
Listed
Labeler
Padagis Israel Pharmaceuticals Ltd
Dosage form
SPRAY
Route
NASAL
Product type
HUMAN OTC DRUG
Marketing category
ANDA
Application
ANDA211951
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/45802-578 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • NALOXONE HYDROCHLORIDE4 mg/.1mL

Pharmacologic classes

Opioid Antagonist [EPC]; Opioid Antagonists [MoA]

Package NDCNDC-11Package
45802-578-244580205782424 VIAL, SINGLE-DOSE in 1 CARTON (45802-578-24) / .1 mL in 1 VIAL, SINGLE-DOSE (45802-578-00)
45802-578-84458020578842 VIAL, SINGLE-DOSE in 1 CARTON (45802-578-84) / .1 mL in 1 VIAL, SINGLE-DOSE (45802-578-00)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • NADAC price for package 45802057884

    GET /v1/drugs/nadac/45802057884

Use it

Look up 45802-578 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/45802-578 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 45802-578. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.